NL-OMON44183尚未招募不适用
Diffusion changes due to hyperthermia treatment for locally advanced cervical cancer - HT-diffusion-1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with advanced cervical cancer who will receive MRI-guided hyperthermia as part of standard care. In addition, patients need to have a macroscopic tumour at the first hyperthermia treatment.
排除标准
- •Claustrophobia
研究者
相似试验
尚未招募
1 期
Comparison of two different methods of delivery of labour epidural and presence of fever in women in labour.CTRI/2022/03/040785Fluid Research Grant
尚未招募
1 期
The study of intraperitoneal hyperthermic perfusion chemotherapy combined with traditional Chinese medicine on survival status after laparoscopic ovarian cancer reduction surgeryOvarian cancerITMCTR2100004746Chengdu Women's and Children's Central Hospital
进行中（未招募）
不适用
_Ovarian epithelial cancer : intraperitoneal resectable relapseMedDRA version: 17.1Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023035-42-ITICANCER
进行中（未招募）
不适用
Randomized phase III study evaluating hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapseOvarian epithelial Cancer: intraperitoneal resectable relapseMedDRA version: 14.1Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023035-42-ESnicancer444
尚未招募
1 期
TO CHECK THE SAFETY OF WARM CHEMOTHERAPY FOR ADVANCED ORAL CANCERSCTRI/2024/04/065397Tata Memorial Centre